Information JPMA Communication Plan for FY2021 is being developed

Printable PDF

JPMA's Public Affairs Committee has been implementing a communication plan every year to deepen the public's understanding of the pharmaceutical industry. This plan aims to provide information on new drugs and the pharmaceutical industry from a variety of perspectives through the development of various publicity measures, and to familiarize the public with the social value of new drugs, namely, their contribution to extending healthy life expectancy.

The communication plan for FY2021 is based on the renewal of the JPMA website in September 2021 and the start of information dissemination through social networking services (SNS), in response to the further progress in the digitization of communication in the Corona disaster. Based on the renewal of the Pharmaceutical Cooperative's website in September 2021 and the start of information dissemination through SNS, the project will develop three different publicity measures utilizing digital tools, SNS, and events combining real and online activities.

Discovering the Pharmaceutical Industry Experience Project" for students

This project will mainly target young people, including students, and provide them with an opportunity to deepen their understanding of the pharmaceutical industry and to become aware of their future involvement in the industry by participating in a program that combines an online listening seminar and a social gathering or workshop. The program will be divided into three stages from January to March 2022.

In the first stage, applications were solicited from the end of 2021 through student organizations in which students attending science and medical universities participate, and 95 applications were received. This stage was conducted in the form of an "audited seminar" in which participants learned by watching videos that were distributed online exclusively to applicants. the first distribution program on January 21, 2022, featured employees working in the pharmaceutical industry introducing their work in their respective departments, and the distribution program on January 28, 2022, featured presentations by healthcare professionals and other professionals including those involved in patient groups on their work and their The program on the 28th will be a presentation by professionals, including healthcare professionals and those involved in patient groups, about their work and how it relates to the pharmaceutical industry.

The second stage, the next step, was held online for participants of the previous stage, and included an exchange meeting between participants and employees working for pharmaceutical companies. With the participation of employees from JPMA member companies, participants were introduced to the day-to-day operations of three job categories in the pharmaceutical industry: development positions, patient advocacy, and market access and health outcomes research. In addition, participants were divided into small groups for a free talk session, which allowed them to become more familiar with the pharmaceutical industry through interaction with employees.

The final stage was held on March 18, where participants were divided into groups to compile and present presentations based on the results they had learned throughout the entire program, and awards for excellence were presented. A report on this event will be available on the special website from March onward.

Special website: https://www.jpma.or.jp/lp/

 Audience-oriented seminar DAY 1 featuring Stage 1 employees Audience-oriented seminar DAY 1 featuring Stage 1 employees

YouTube video: Communicating the value of new drugs

A YouTube video featuring "Aoi," a student at the Faculty of Pharmacy, was distributed mainly targeting the elderly demographic. The videos feature familiar diseases such as "prevention and treatment of infectious diseases," "cardiovascular diseases," and "asthma," to remind viewers of how the introduction of new drugs has contributed to treatments and people's health, and to convey the importance of innovation in drug discovery. Dr. Yutaka Morita, a physician, also makes an appearance as an animated character in the video, and he and Aoi interact with each other humorously as they delve deeper into the themes of each episode, creating an approachable structure.

There are eight disease themes, and a doctor specializing in each theme discusses the world before and after the advent of new drugs. All eight videos were released on the JPMA YouTube channel by early March 2022.

 Special site banner #1 Special site banner #1

 Thumbnail image of #1 Thumbnail image of #1

Special website: https://www.jpma.or.jp/lp/aoi/
JPMA YouTube channel: https://www.youtube.com/channel/UCaQ0-gUGYxRSY5v2hVByS4g

  1. Contents of the program
  2. Program #1
    What's so great about the new coronary [vaccine]?
  3. #2
    What's so great about [drugs for infectious diseases]?
  4. 3.
    What is the treatment of asthma?
  5. 4.
    What is the treatment of leukemia?
  6. 5.
    What is the treatment for cerebral infarction?
  7. 6.
    What is the treatment for renal anemia?
  8. 7.
    What is the treatment of rheumatoid arthritis like?
  9. 8.
    What is the treatment of breast cancer like?

Digital Mook" tie-up with "Tokyo Graffiti

In a tie-up with "Tokyo Graffiti," a culture magazine for young people that takes up social themes from a fresh perspective, a digital mook was produced to collect the voices of "What to Expect from New Drugs. The aim is to encourage people to "personalize" the birth of new drugs and deepen their understanding of the current state of Japan's pharmaceutical industry. Interviews were conducted with young people, including students, parents, and working adults, on the theme of "what kind of drug would you like to have? A collage of their voices is also included in the "I see! The World of Pharmaceuticals! page, which provides data and information on Japan's pharmaceutical industry with illustrations and graphs, and "Want to Know: The Frontlines of New Drug Development! The "Frontlines of New Drug Development! page provides easy-to-understand explanations of the latest topics in the pharmaceutical industry, such as AI drug discovery and big data. This digital mook will be available on the JPMA website from March 2022.

Special website: https://www.jpma.or.jp/news_room/campaign/campaign2021/

 Image of the magazine Image of the magazine

The JPMA Twitter account (https://twitter.com/Seiyakukyou ), which was launched in January 2022, will also be used for publicity measures in FY2021, and will be used to report on the event and provide news.

( Tomoko Arai, Public Relations Department)

Share this page

TOP